Little pharma gets big boost from drug regulators

  • 📰 Breakingviews
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

A drug for ALS or motor neuron disease received a green light from an FDA panel instead of waiting for further trial results. The unusual decision can be justified in this case, but such fast-tracking should be rare, says rob_cyran.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 470. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA panel backs much-debated ALS drug in rare, 2nd reviewWASHINGTON (AP) — A panel of federal health advisers voted Wednesday to recommend approval for an experimental drug to treat Lou Gehrig’s disease, a remarkable turnaround for the much-debated medication that was previously rejected by the same group earlier this year. Flakes
Source: AP - 🏆 728. / 51 Read more »

FDA Approves New Botox RivalThe U.S. Food and Drug Administration approved a new antiwrinkle treatment that could be the most formidable challenger to date to market leader Botox
Source: WSJhealth - 🏆 413. / 53 Read more »